BIOMAT Database Logo BIOMAT Database Logo

Altered antibody isotype in cystic fibrosis: impaired natural antibody response to polysaccharide antigens. 1987

R B Moss, and Y P Hsu, and P H Van Eede, and A M Van Leeuwen, and N J Lewiston, and G De Lange
Ross Mosier Laboratory for Cystic Fibrosis Research, Children's Hospital-Stanford, Department of Pediatrics, Stanford University Medical School, Palo Alto, CA 94304.

Patients with cystic fibrosis (CF) have impaired natural (preinfection) IgG2 antibody responses to Pseudomonas aeruginosa lipopolysaccharide. To investigate the basis for this defect, we measured natural IgG and IgG1-4 antibody levels to Haemophilus influenzae type b polyribophosphate (PRP) and tetanus toxoid by enzyme-linked immunosorbent assay in 24 adult CF patients and 20 normal controls. Immunoglobulin heavy- and light-chain allotypes were determined on 146 Caucasian CF patients and 96 controls. The tetanus toxoid-specific IgG response was predominantly IgG1. CF and control subjects had similar IgG and IgG1 antibody levels. The PRP-specific IgG response was predominantly IgG2. In contrast to tetanus toxoid results, CF patients had lower geometric mean level of PRP-specific IgG compared to normal controls (p = 0.0036). ELISA results were confirmed by liquid-phase 3H-PRP-binding assay: CF patients had a geometric mean serum antibody level of 395 versus 922 ng/ml in controls (p = 0.0044). PRP-specific IgG2 levels were also depressed in CF patients (p = 0.03). CF patients had a lower prevalence of the A2m(2) allotype than the local racially matched control sample (p less than 0.025). Other allotype prevalences including G2m(n) and Km(1) were similar. Impaired IgG2 antibody responses to microbial polysaccharide surface antigens in CF patients might predispose them to persistent endobronchial infection and lead to production of nonopsonizing isotype responses. The potential role of A2m(2), coded for in the H chain locus on chromosome 14, is unknown, but could be related to mucosal IgA2 antibody responses.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007129 Immunoglobulin Gm Allotypes Allelic variants of the gamma-immunoglobulin heavy chain (IMMUNOGLOBULIN GAMMA-CHAINS) encoded by ALLELES of IMMUNOGLOBULIN HEAVY CHAIN GENES. Allotypes, Immunoglobulin Gm,Gm Allotypes,Ig Gm Allotypes,Allotype, Gm,Allotype, Ig Gm,Allotype, Immunoglobulin Gm,Allotypes, Gm,Allotypes, Ig Gm,Gm Allotype,Gm Allotype, Ig,Gm Allotype, Immunoglobulin,Gm Allotypes, Ig,Gm Allotypes, Immunoglobulin,Ig Gm Allotype,Immunoglobulin Gm Allotype
D008297 Male Males
D010428 Pentosephosphates
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005260 Female Females
D006193 Haemophilus influenzae A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII. Bacterium influenzae,Coccobacillus pfeifferi,Haemophilus meningitidis,Hemophilus influenzae,Influenza-bacillus,Mycobacterium influenzae
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R B Moss, and Y P Hsu, and P H Van Eede, and A M Van Leeuwen, and N J Lewiston, and G De Lange
Antibody response to Pseudomonas aeruginosa antigens in cystic fibrosis.
January 1989, Antibiotics and chemotherapy,
R B Moss, and Y P Hsu, and P H Van Eede, and A M Van Leeuwen, and N J Lewiston, and G De Lange
Immunoglobulin isotype in the murine response to polysaccharide antigens.
March 1983, European journal of immunology,
R B Moss, and Y P Hsu, and P H Van Eede, and A M Van Leeuwen, and N J Lewiston, and G De Lange
Increased serum antibody levels to dietary antigens in cystic fibrosis.
April 1994, Acta paediatrica (Oslo, Norway : 1992),
R B Moss, and Y P Hsu, and P H Van Eede, and A M Van Leeuwen, and N J Lewiston, and G De Lange
Isotype antibody response in cows to Streptococcus agalactiae group B polysaccharide-ovalbumin conjugate.
July 1992, Journal of clinical microbiology,
R B Moss, and Y P Hsu, and P H Van Eede, and A M Van Leeuwen, and N J Lewiston, and G De Lange
T cell function in patients with impaired antibody responses to polysaccharide antigens.
September 1991, European journal of immunology,
R B Moss, and Y P Hsu, and P H Van Eede, and A M Van Leeuwen, and N J Lewiston, and G De Lange
Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.
November 1992, Clinical and experimental immunology,
R B Moss, and Y P Hsu, and P H Van Eede, and A M Van Leeuwen, and N J Lewiston, and G De Lange
Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA.
May 2005, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
R B Moss, and Y P Hsu, and P H Van Eede, and A M Van Leeuwen, and N J Lewiston, and G De Lange
T-cell modulation of the antibody response to bacterial polysaccharide antigens.
January 1989, Infection and immunity,
R B Moss, and Y P Hsu, and P H Van Eede, and A M Van Leeuwen, and N J Lewiston, and G De Lange
Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
April 2009, Pediatric pulmonology,
R B Moss, and Y P Hsu, and P H Van Eede, and A M Van Leeuwen, and N J Lewiston, and G De Lange
Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis.
January 1991, Pediatric pulmonology,
Copied contents to your clipboard!